{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:06:52Z","timestamp":1792901212949,"version":"4.5.0"},"reference-count":41,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2018]]},"DOI":"10.3164\/jcbn.17-73","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:13:02Z","timestamp":1515622382000},"page":"179-186","source":"Crossref","is-referenced-by-count":42,"title":["A double blind, placebo-controlled, randomized clinical trial that breast milk derived-&lt;i&gt;Lactobacillus gasseri&lt;\/i&gt; BNR17 mitigated diarrhea-dominant irritable bowel syndrome"],"prefix":"10.3164","volume":"62","author":[{"given":"Suk Pyo","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hallym University Sacred Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Mi","family":"Choi","sequence":"additional","affiliation":[{"name":"Digestive Disease Center, CHA University Bundang Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Digestive Disease Center, CHA University Bundang Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Pyo","family":"Hong","sequence":"additional","affiliation":[{"name":"Digestive Disease Center, CHA University Bundang Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Park","sequence":"additional","affiliation":[{"name":"CHA Bio Complex CHA Cancer Prevention Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nutritional Science and Food management, Ewha Woman University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oran","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Nutritional Science and Food management, Ewha Woman University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health, Ajou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Baik","family":"Hahm","sequence":"additional","affiliation":[{"name":"Digestive Disease Center, CHA University Bundang Medical Center"},{"name":"CHA Bio Complex CHA Cancer Prevention Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011; 45 Suppl: S149\u2013S153.","DOI":"10.1097\/MCG.0b013e3182257e98"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Issa I, Moucari R. Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol 2014; 20: 17788\u201317795.","DOI":"10.3748\/wjg.v20.i47.17788"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Guandalini S, Cernat E, Moscoso D. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Benef Microbes 2015; 6: 209\u2013217.","DOI":"10.3920\/BM2014.0067"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29: 184\u2013189.","DOI":"10.1097\/MOG.0b013e32835d7bba"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yoon H, Park YS, Lee DH, Seo JG, Shin CM, Kim N. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Biochem Nutr 2015; 57: 129\u2013134.","DOI":"10.3164\/jcbn.15-14"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hou X, Chen S, Zhang Y, et al. Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. Clin Drug Investig 2014; 34: 783\u2013793.","DOI":"10.1007\/s40261-014-0233-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Monnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011; 45 Suppl: S98\u2013S101.","DOI":"10.1097\/MCG.0b013e31821fbf44"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Park JM, Choi MG, Kim YS, et al. Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res 2009; 18: 435\u2013446.","DOI":"10.1007\/s11136-009-9461-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ma AD, Kessler CM, Al-Mondhiry HA, Gut RZ, Cooper DL. Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study. Blood Coagul Fibrinolysis 2016; 27: 753\u2013760.","DOI":"10.1097\/MBC.0000000000000471"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ishimoto H, Oshima T, Sei H, et al. Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients. J Clin Biochem Nutr 2017; 60: 146\u2013150.","DOI":"10.3164\/jcbn.16-92"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Belkind-Gerson J, Tran K, Di Lorenzo C. Novel techniques to study colonic motor function in children. Curr Gastroenterol Rep 2013; 15: 335.","DOI":"10.1007\/s11894-013-0335-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr 2015; 174: 151\u2013167.","DOI":"10.1007\/s00431-014-2476-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013; 145: 946\u2013953.","DOI":"10.1053\/j.gastro.2013.08.058"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kang JH, Yun SI, Park HO. Effects of <i>Lactobacillus gasseri<\/i> BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol 2010; 48: 712\u2013714.","DOI":"10.1007\/s12275-010-0363-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. Anti-obesity effect of <i>Lactobacillus gasseri<\/i> BNR17 in high-sucrose diet-induced obese mice. PLoS One 2013; 8: e54617.","DOI":"10.1371\/journal.pone.0054617"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Jung SP, Lee KM, Kang JH, et al. Effect of <i>Lactobacillus gasseri<\/i> BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Fam Med 2013; 34: 80\u201389.","DOI":"10.4082\/kjfm.2013.34.2.80"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lee EH, Kwon O, Hahm KB, et al. Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation. Health Qual Life Outcomes 2016; 14: 22.","DOI":"10.1186\/s12955-016-0423-9"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G, Castellazzi AM. Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes 2017. DOI: 10.1080\/19490976.2017.1345414","DOI":"10.1080\/19490976.2017.1345414"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing <i>Bifidobacterium animalis<\/i> DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475\u2013486.","DOI":"10.1111\/j.1365-2036.2007.03362.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Lorenzo-Z\u00fa\u00f1iga V, Llop E, Su\u00e1rez C, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014; 20: 8709\u20138716.","DOI":"10.3748\/wjg.v20.i26.8709"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: <i>Bifidobacterium bifidum<\/i> MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 1123\u20131132.","DOI":"10.1111\/j.1365-2036.2011.04633.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Guandalini S, Magazz\u00f9 G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010; 51: 24\u201330.","DOI":"10.1097\/MPG.0b013e3181ca4d95"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 O&apos;Sullivan MA, O&apos;Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000; 32: 294\u2013301.","DOI":"10.1016\/S1590-8658(00)80021-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of <i>Lactobacillus plantarum<\/i> 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002; 47: 2615\u20132620.","DOI":"10.1023\/A:1020597001460"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Newcomer AD, Park HS, O&apos;Brien PC, McGill DB. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Am J Clin Nutr 1983; 38: 257\u2013263.","DOI":"10.1093\/ajcn\/38.2.257"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of <i>Lactobacillus reuteri<\/i> ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr 2005; 24: 925\u2013931.","DOI":"10.1016\/j.clnu.2005.06.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 2011; 45: 679\u2013683.","DOI":"10.1097\/MCG.0b013e318204593e"},{"key":"28","unstructured":"28 Kabir MA, Ishaque SM, Ali MS, Mahmuduzzaman M, Hasan M. Role of <i>Saccharomyces boulardii<\/i> in diarrhea predominant irritable bowel syndrome. Mymensingh Med J 2011; 20: 397\u2013401."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005; 17: 332\u2013340.","DOI":"10.1111\/j.1365-2982.2005.00650.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20 Suppl 2: 1\u20139.","DOI":"10.1111\/j.1365-2036.2004.02036.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Corbett CL, Thomas S, Read NW, Hobson N, Bergman I, Holdsworth CD. Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome. Gut 1981; 22: 836\u2013840.","DOI":"10.1136\/gut.22.10.836"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Lu WZ, Song GH, Gwee KA. Ho KY. The effects of melatonin on colonic transit time in normal controls and IBS patients. Dig Dis Sci 2009; 54: 1087\u20131093.","DOI":"10.1007\/s10620-008-0463-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Horikawa Y, Mieno H, Inoue M, Kajiyama G. Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers. Scand J Gastroenterol 1999; 34: 1190\u20131195.","DOI":"10.1080\/003655299750024698"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil 2010; 16: 120\u2013130.","DOI":"10.5056\/jnm.2010.16.2.120"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17: 687\u2013696.","DOI":"10.1111\/j.1365-2982.2005.00695.x"},{"key":"36","unstructured":"36 Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20: 8886\u20138897."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Jeffery IB, O&apos;Toole PW, \u00d6hman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997\u20131006.","DOI":"10.1136\/gutjnl-2011-301501"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Rajili\u0107-Stojanovi\u0107 M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792\u20131801.","DOI":"10.1053\/j.gastro.2011.07.043"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Krogius-Kurikka L, Lyra A, Malinen E, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009; 9: 95.","DOI":"10.1186\/1471-230X-9-95"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Yun SI, Park HO, Kang JH. Effect of <i>Lactobacillus gasseri<\/i> BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009; 107: 1681\u20131686.","DOI":"10.1111\/j.1365-2672.2009.04350.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Bouchoucha M, Nalpas B, Berger M, Cugnenc PH, Barbier JP. Recovery from disturbed colonic transit time after alcohol withdrawal. Dis Colon Rectum 1991; 34: 111\u2013114.","DOI":"10.1007\/BF02049982"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/62\/2\/62_17-73\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T06:49:46Z","timestamp":1570603786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/62\/2\/62_17-73\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.17-73","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}